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Abstract
Background: Phosphopeptide-binding domains mediate many vital cellular processes such as signal transduction
and protein recognition. We studied three well-known domains important for signal transduction: BRCT repeats,
WW domain and forkhead-associated (FHA) domain. The first two recognize both phosphothreonine (pThr) and
phosphoserine (pSer) residues, but FHA has high specificity for pThr residues. Here we used molecular dynamics
(MD) simulations to reveal how FHA exclusively chooses pThr and how BRCT and WW recognize both pThr/pSer.
The work also investigated the energies and thermodynamic information of intermolecular interactions.
Results: Simulations carried out included wide-type and mutated systems. Through analysis of MD simulations, we
found that the conserved His residue defines dual loops feature of the FHA domain, which creates a small cavity
reserved for only the methyl group of pThr. These well-organized loop interactions directly response to the pThr
binding selectivity, while single loop (the 2nd phosphobinding site of FHA) or in combination with a-helix (BRCT
repeats) or b-sheet (WW domain) fail to differentiate pThr/pSer.
Conclusions: Understanding the domain pre-organizations constructed by conserved residues and the driving
force of domain-phosphopeptide recognition provides structural insight into pThr specific binding, which also
helps in engineering proteins and designing peptide inhibitors.
Background
Protein phosphorylation is widely exploited in DNA
damage repair, signal transduction, cell growth and cell
cycle regulation; the cascades of downstream signals can
be triggered by grabbing a certain phosphoprotein [1-6].
Elucidating the characteristics of phosphopeptide recogni-
tion is fundamental to study cellular functions [7]. The
phosphoproteins are usually classified into two families,
phosphotyrosine (pTyr)-containing and phosphoserine
(pSer)/phosphothreonine (pThr)-containing sequences
which are phosphorylated and dephosphorylated by dif-
ferent categories of kinases (e.g., pThr/pSer kinase and
pThr kinase) and phosphatases [8]. Recent studies discov-
ered a few modular domains that particularly recognize
pThr/pSer- or pThr-containing sequences, such as the
breast-cancer-associated protein BRCA1 C-terminal
(BRCT) repeats, WW domain and forkhead-associated
(FHA) domain [9]. Among them, the FHA domain differ-
entiates pThr-containing peptides from pSer-containing
peptides, although the difference is only one methyl
group [10-15]. Because Ser/Thr kinase phosphorylates
both residues, the FHA domain can efficiently reduce
potential interaction sites by specifically binding to pThr-
containing regions. Although experimental structures and
recent studies have shown important interactions involve
in the binding of the methyl group of pThr [14,16], the
detailed mechanisms of the phosphoresidue recognition
of different domains and how the FHA domain can
reserve non-polar interactions for a small non-polar
methyl group are not fully understood.
The FHA domain is associated with proteins of
diverse functions in different organisms. For example,
the Rad53-FHA1 domain interacts with phosphorylated
Rad9 in response to DNA damage, and the Dun1-FHA
domain interacts with SCD1 of Rad53, which leads to
activation of Dun1in response to DNA damage response
[17]. Instead of binding to a single pThr, the formation * Correspondence: chiaenc@ucr.edu
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phoresidues, which suggests a potential mechanism
whereby sequential signaling events could be triggered
through the recognition of multiple phosphoresidue-
binding sites. Similar to Dun1-FHA, Ki67-FHA domain
also recognizes dual phosphorylated residues at the
same time [18], and the sequence identities of Dun1-
FHA and the Ki67-FHA to Rad53-FHA1 are both 34%.
The structure of the FHA domain is mostly organized
into a twisted b sandwich of 11 well-defined b sheets,
five in the front and six at the back (Figure 1 (a))
[12,14,16,19-23]. The domain contains ~120 to 140 resi-
dues, but only five to ten residues are conserved. Six
loops connected to the secondary b strands constructing
the pThr binding site are the main difference between
distinct FHA domains. Experimental structures show
that the synthetic peptides bind to the loops between
b3-b4, b4-b5, b6-b7a n db10-b11, and the conserved
pThr binding site locates between loops b4-b5a n db6-
b7 (Figure 1 (a)) [12,14].
BRCT repeats in BRCA1 are considered to be related
to breast cancer [24-27]. The structure of the tandem
BRCA1-BRCT repeats bind to phosphorylated protein
that contains pSer or pThr, although binding to pSer is
preferred [28]. Several structural studies have revealed a
conserved structure for the repeats, mainly composed of
a helixes, b sheets and loops that link secondary struc-
tures. The phosphoresidue-recognized site is located
between b1 and a2 (Figure 1 (b)) [29-31].
The WW domain in Pin1 is essential for mitotic pro-
gression [32]. The domain has only about 40 residues and
is one of the smallest pThr/pSer binding domains [3]. It
specifically binds to pThr-Pro- or pSer-Pro-containing
motifs with slightly higher affinity for pThr-Pro-containing
peptides [33]. For example, in the Pin1-WW domain, the
aromatic rings of Tyr23 and Trp34 define a steric clamp
to confer a Pro adjacent to pSer/pThr [34]. The WW
domain folds into three anti-parallel b stands and Arg21
and Ser22 residues in the loops between b1a n db2 are the
phosphate group recognition sites (Figure 1 (c)) [3,4,34].
Figure 1 Overall architecture of signaling domains. (a) Snapshot of Rad53-FHA1 molecular dynamics (MD) simulations. Pink and blue
represent front and back loop/b-strand respectively. (b) Snapshot of an MD simulation for BRCT repeats in BRCA1. (c) WW domain in Pin1
protein.
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domains, this study focused on how FHA domains dis-
play selective for pThr/pSer residues and comparison
with BRCT and WW domains. We study the dynamic
and conformational changes of the free domain and the
complexes of Rad53-FHA1:Rad9, Dun1-FHA:SCD1,
Ki67-FHA:hNIFK, BRCA1-BRCT:BRCH1 and Pin1-WW:
CTD systems. We also computed the interaction energy
between pThr/pSer and the domains to disclose the
driving force of pThr/pSer binding. We propose a
model for pThr specificity and potential applications.
Methods
Molecular systems
We selected three FHA domains in different families,
BRCT repeats and the WW domain. One of the FHA
domains is the human Chk2 homolog in yeast, Rad53-
FHA1, involved in checkpoint signaling in Saccharo-
myces. Serevisiae. The target protein of Rad53, Rad9, is
phosphorylated in response to DNA damage and inter-
acts with the C-terminal FHA1 domain of Rad53. Two
initial structures are from crystallographic coordinates
(Protein Data Bank (PDB) code 1G6G) [12] and NMR
structure (PDB code 1K3Q) [16]. Both Rad53-FHA1
domains share the same protein sequence. Another
FHA domain is from the Dun1 checkpoint kinase. The
Dun1-FHA domain interacts with phosphorylated SCD1
of Rad53, which leads to activation of Dun1. The Dun1-
FHA and SCD1complex of the domain-peptide structure
is acquired from the PDB code 2JQL[35]. The other sys-
tem of the FHA domain near the N-terminus of human
Ki67 antigen protein that interacts with human nucleo-
lar protein hNIFK was studied a few years ago. The
structural complex of Ki67-FHA and a 44-residues frag-
ment in phosphorylated hNIFK is explored by the coor-
dinates of the PDB code 2AFF[18]. We chose to study
the pThr/pSer binding modular domain (PDB code
1T2V) of the complex of the BRCT domain in the
BRCA1 C-terminus and its target binding partner,
BRCH1 [29]. Another phosphodomain, the WW domain
from the Pin1 N-terminus, interacts with the heptapho-
phorylated peptide in the CTD domain (PDB code
1F8A) [34]. Although the peptide contains two pSer
residues, only one binds to the domain. All peptide
sequences are in Table 1. To study the recognition for
phosphoresidue and how FHA domains differentiate the
pThr/pSer residue, we manually mutated pThr to pSer
or pSer to pThr in phosphopeptides. The mutated sites
are shown in Table 1.
Molecular dynamics simulation
We performed molecular dynamics (MD) simulations
using the Amber10 and NAMD2.6 simulation packages
with the ff99sb amber force field [36-38]. Because
phosphoresidues are not defined in the ff99sb force
field, we used the pThr and pSer force field developed
by Homeyer et al. [39]. All simulations of wild-type
sequences were initialed from six experimental com-
plexes. In this work, we studied six un-mutated com-
plexes and eight mutated structures. The protonation
states were checked by the MCCE program [40]. All
complexes were solvated in a rectangular box of 12 Å
TIP3P water with the tleap program in Amber10 [41].
The placement of counter-ions of Na
+ was based on the
Columbic potential to keep the whole system neutral.
Particle Mesh Ewald was used to consider the long-
range electrostatic interactions [42]. Following 10,000
and 20,000 steps of minimization of the water and sys-
tem, respectively, the systems were gradually heated for
each complex from 250 K for 20-ps, 275 K for 20-ps
and 300 K for 200-ps. To initial the mutated structures,
after equilibrium from 300 K, we manually added or
deleted the methyl group and changed the residue name
accordingly, then used the Amber program to build the
prmtop files for mutants. A quick 100-steps minimiza-
tion was applied to the mutants, then we preformed 20-
ps equilibrium at 300 K. All MD simulations for each
wild-type and mutated complex was performed in 1 ns
by five different random number seeds to generate dif-
ferent initial velocity. The resulting trajectories were col-
lected every 1 ps and the time step was 2-fs. The NPT
ensemble was applied, and periodic boundary conditions
were used throughout the MD simulations. A tempera-
ture of 300 K was maintained with use of a Langevin
thermostat, with a damping constant of 2 ps
-1,a n dt h e
hybrid Nose-Hoover Langevin piston method was used
to control the pressure at 1 atm. The SHAKE procedure
was used to constrain hydrogen atoms during MD simu-
lations [43].
Binding energy calculation by MM-PBSA methods and
entropy calculation
To quantify the stability of the phosphopeptide binding
to the domain, we performed end-point energy calcula-
tions, also known as MM-PBSA/MM-GBSA calculations
[44-50]. A simple thermodynamic cycle and single-tra-
jectory post-processing allows for efficiently computing
the various contributions to the domain-peptide binding.
We used the structural ensemble obtained from the final
1-ns of each random number seed to demonstrate the
post-energy calculations. The binding interaction energy,
ΔEbind, associated with the binding of a domain to its
cognate peptide to form a protein-peptide complex is
calculated as follows:
 Ebind =< Ecomplex > − < Edomain > − < Ephosphopeptide > (1)
The bracket <E > denotes the average energy com-
puted from a given MD trajectory. The changes in
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posed as follows:
 Ebind =  Ev +  Evdw +  ECoul +  WPB/ WGB +  Wnp, (2)
representing the changes in valance (v) energy (bond,
angle, dihedral, and improper dihedral energies), van der
Waal (vdw) interactions, Coulombic (Coul) interactions,
and solvation free energy ΔWPB/ΔWGB and ΔWnp.W e
note that the binding energy computed here includes
the solvation free energy which considers water entropy,
and the valance energies cancel out in Eq. 2 due to the
single trajectory approach. The solvation free energy can
be further decomposed into the polar term, ΔWPB/
ΔWGB, and non-polar cavity term, ΔWnp term [44,51].
Here, we demonstrate two methods, Poisson-Boltzmann
(PB) and Generalized-Born (GB), to estimate the polar
solvation term [45,46]. PB was calculated by solving the
PB equation in the PBSA model of Amber11. The
dielectric constants of the interior and exterior protein
were set to 1 and 80 respectively. GB (igb = 1) was used
in the sander program of Amber11 package. The non-
polar solvation term was calculated by the solvent-acces-
sible surface area (SASA) model. All energy involved a
40 Å cutoff value for non-bonded interactions.
The configuration entropy S consisted of phi, psi,
omega and sidechain dihedrals, which include both con-
formational (number of energy wells) and vibrational
entropy (width of an energy well) [47,48,52]. We com-





where p(x) is the probability distribution of dihedral x,
and R is the gas constant. T-analyst was used to com-
pute the Gibbs entropy [53]. We considered only the
internal dihedral degree of freedom of each dihedral,
and the coupling between dihedrals was ignored. The
change in configuration entropy during the mutation
can be presented as follows:
T SX =T  SX, mutated − T SX, wild-type, (4)
where X denotes each dihedral angle, such as phi, psi,
omega and sidechain.
Results and discussion
Ser and Thr have very similar sidechains, so the Ser/Thr
protein kinases phosphorylate the OH group of either
residue without discriminating between them. Similarly,
most pSer/pThr binding modules, such as BRCT and
WW domains, can specifically bind to short pSer/pThr-
containing motifs equally well. Not unsurprisingly, one
more methyl group of Thr has few effects on the overall
binding and molecular recognition. However, uniquely,
most FHA domains recognize only pThr residues in tar-
get proteins, and substitution of pSer for pThr in model
peptides severely weakens binding. The pThr specific
recognition may function as a filter to further select the
protein partner.
One of our aims was to investigate how FHA domains
can distinguish the tiny difference between Ser and Thr
in their binding partner. The work helps gain deeper
understanding in molecular recognition and provides
valuable insight into strategies of protein engineering.
Although we have simulated the entire FHA, WW and
BRCT systems, we do not attempt to draw conclusions
on properties of the whole system. Instead, we focus on
the phosphoresidue binding region, in particular pThr
or pSer. Multiple 1 ns MD simulations were performed
for each system with different initial velocity so that the
simulations evolve independently of each other to
reduce potential bias caused by the initial conformation.
Because the short phosphopeptides are highly flexible,
carrying out short simulations allows the peptide to stay
in similar local energy well during different runs [54,55].
The root mean square deviation (RMSD) of selected sys-
tems is shown in Figure S1 of Additional file 1.
To obtain an estimate of the differences in interaction
energies of the domain with its pSer- or pThr-contain-
ing peptides, we post-processed our MD trajectories and
computed the domain-peptide interaction energies,
including the potential energy and solvation energy. The
method is usually called the MM-PBSA method. We
computed intermolecular interactions between the
Table 1 Peptide sequences of domain-phosphopeptide complexes
domain Protein PDB ID Method Phosphopeptide Kd(μM) Ref.
FHA1 Rad53 1G6G X-ray LEV(pT)EADATFAK 0.53 (12)
FHA1 Rad53 1K3Q NMR SLEV(pT)EADATFVQ 0.3 (16)
FHA Dun1 2JQL NMR NI(pT)QP(pT)QQST 0.3-1.2 (35)
FHA Ki67 2AFF NMR KTVD(pS)QGP(pT)PVC(pT)PTFLERRKSQVAELNDDDKDDEIVFKQPISC 0.077 (18)
BRCT BRCA1 1T2V X-ray AAYDI(pS)QVFPFA 0.4 (29)
WW Pin1 1F8A X-ray Y(pS)PT(pS)PS 34 (34)
Residues in the bracket are either pT or pS. The first mutation site is represented by both underline and bold, and the second mutation site is underlined.
Secondary structures, a helix and b sheet, are labeled as italic with underline and italic, respectively.
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binding energy calculation”. In our global energy calcu-
lations, the solvation energy term includes a PB term,
WPB, for electrostatic solvation free energy, and a cavity/
surface area term, Wnp, for nonpolar solvation free
energy. Because we are particularly interested in study-
ing the local region that contributes significantly to
pThr or pSer recognition, we also selected residues
within 5 to 7 Å of the phosphate group (Table S3 in
Additional file 1) to calculate interaction energies
between the residues chosen. We called the calculations
between these selected residues “local interaction energy
calculation”. Because the calculations involved only resi-
dues near the binding sites, the solvation energies com-
puted by the PB or GB model are similar. As a result,
we used the GB model in our local energy calculation to
speed up the calculation.
Revealing the specificity of the main pThr-binding site in
FHA domains
In the FHA domain family, the loops that link two b-
sheets appear to play a pivotal role in constructing the
binding pocket for pThr-containing peptides. Despite
the variability of primitive sequences in the loop area in
different FHA-containing proteins such as Rad53-FHA1,
Dun1-FHA and Ki67-FHA, analysis of FHA domain
conformations suggests a conserved structure in the
main pThr-binding site formed by two loops between
b3-b4 and b6-b7 (see Figure 2 (A1)).
We substituted pThr with pSer in silico,a n dt h eg l o -
bal binding energy calculations show that pSer-contain-
ing peptides have 3-6 kcal/mol higher binding energies
than the pThr-containing peptide. Notably, the binding
energy calculations are for potential (MM) and solvation
(PB/SA) energy only, and the entropic changes upon
binding are not included here. Of interest is knowing
which energy term contributes more to weaken the
FHA domain-peptide interaction. Because the only dif-
ference between pThr and pSer is one non-polar methyl
group, the pSer-containing peptide may reasonably
result in less favorable van der Waals attraction. How-
ever, the trend is not clear, which suggests that repla-
cing pThr by pSer may affect interactions between
pThr/pSer and the domain, and the stability of the
entire peptide binding to the protein. For example,
pSer-containing peptides have weaker van der Waals
interactions between Rad53-FHA1 and Ki67-FHA (Table
2), but the interaction is in the opposite direction for
Dun1-FHA. Moreover, the Ki67-FHA:pSer-peptide com-
plex shows slightly more favorable electrostatic attrac-
tion (-0.98 kcal/mol) as compared with the Ki67-FHA1:
pThr-peptide complex. However, the Rad53-FHA1:pSer-
peptide and Dun1-FHA1:pSer-peptide complexes have
weaker electrostatic interactions. Of note, the polar
contributions from the solvation model (PB term) are
mostly compensated with the Coulombic term. There-
fore, although all FHA:pSer-peptide complexes can form
more stable Coulombic interactions, they also result in
less stable solvation energy (PB term). In summary, in
considering all energy terms, pThr-containing peptides
are still highly favored, and our results are in good
agreement with other experiments [12,16].
We also performed local interaction energy calcula-
tions and focused on the interactions between pSer/
pThr and residues around the phosphoresidue to reveal
how FHA can discriminate between them. Although the
only difference between the Thr and Ser residue is one
methyl group, which is usually considered not signifi-
cant, our study indicates that the methyl group directly
interacts with residues of loops b4-b5a n db6-b7o ft h e
FHA domain (see Figure 2 (A2) and (A3)). Again, the
trend agrees with the global binding energy calculations,
and the local interaction energy is less favorable when
pThr is replaced by pSer. The local interaction energy
calculations show that van der Waals interactions are
weakened considerably by the lack of a single methyl
group of pSer; the loss of the van der Waals attraction
can be weakened by ~3 kcal/mol (Table 3). The interac-
tion between the methyl group of pThr and the nearby
residues are unlikely to be 3 kcal/mol, but instead, the
computed energy reveals the crucial role of the methyl
group to stabilize the complex conformation locally.
Interestingly, although the phosphate group of pSer still
retains hydrogen bonding between the nearby residues
of FHA, the electrostatic attractions are still weakened.
This again supports that solely forming H-bonds
between the phosphate group of the phosphoresidue is
not enough for phosphopeptide and FHA domain bind-
ing, and lacking the methyl group destabilizes the com-
plex. As illustrated in Figure 1 (A2) (A3) and Figure S2
in Additional file 1, fewer contacts can be formed when
pSer is present in the peptide.
Of note, although experimental structures demon-
strate a pocket to accept the pThr methyl group, the
static conformation cannot ascertain that pSer fails to
form equally good interactions with the nearby residues,
because the protein is dynamic and may fill the space by
slightly changing the protein conformations. Neverthe-
less, our MD simulations show that the cavity is highly
suited to pThr, and small changes in this particular resi-
due can diminish the domain-peptide interactions.
Because pSer shows less perfect geometry complemen-
tary to the binding cavity of the FHA domain, we also
studied whether the local flexibility is changed because
of the lack of the methyl group. The rotameric states of
each sidechain of phosphopeptides, as well as their con-
figuration entropy, were calculated. Most sidechain dihe-
drals stay in the same rotametic states for both pSer/
Huang and Chang BMC Biophysics 2011, 4:12
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Page 5 of 13Figure 2 Detailed illustration of pThr binding in Rad53-FHA1 main binding site (A), Dun1-FHA second binding site (B), BRCT repeats
(C) and WW domain (D). The binding areas are circled in red (see (1) on the left side). Residues surrounding pThr and pSer residues are in (2)
and (3), respectively. Atom pairs that have charge interactions with phosphoresidues are shown with a blue dashed line. Figures are a snapshot
of our MD simulations.
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Page 6 of 13pThr residues, but the second pThr sidechain dihedral
angle (see Figure 3 (A)) differs. Figure 3 (B1) and (B2)
shows the distribution of the sidechain dihedral angle of
pThr and pSer in Rad53-FHA1 peptide. The dihedral of
pSer deviates from pThr with an angle shift from 115 to
162 degrees, and also has wider distribution, so the
dihedral is more flexible. Clearly, the methyl group of
pThr allows the phosphoresidue to fill the entire pocket
of the binding site, and no room is available for spacious
vibration of the pThr sidechain. In contrast, the space
released by the absence of pSer cannot be adequately
filled by protein sidechains, which creates room for the
dihedral of pSer to be more flexible. Although side-
chains of the dual loops are mobile, the conserved His,
located at the N-terminus of b5, uses the imidazole ring
and polar interactions to form stable interactions with
residues of loops b4-b5a n db6-b7. For example, Figure
4 (C) shows that His can interact with the conserved
S e r 8 5o fl o o pb4-b5 and Ile104 and Gly108 of loop b6-
b7 in Rad53-FHA1. During our MD simulations, the
sidechains moved between the two loops, which
strengthens the interactions between residues around
His (e.g., Ser85 and Thr106) and generates a proper
space exclusively for the methyl group. The same move-
ment and enhanced interactions for forming a cavity are
observed in multiple 50 ns simulations (data not
shown). Therefore, our simulations explain how FHA
makes use of the conserved His to stabilize the dual
loop and form a structural room to dock the methyl
group and discriminate pThr/pSer.
To quantify the flexibility of dihedral rotation and
vibration of pSer/pThr, we performed Gibbs entropy
calculations. As illustrated in Table 4, the sidechain
dihedral entropy increased ~0.7-1.5 kcal/mol after muta-
tion and the configuration entropy of the entire pSer
residue increased nearly 2 kcal/mol as compared with
pThr. Among all the dihedral angles, the entropy
increase is mostly contributed by sidechain dihedrals.
Notably, the local entropy increase when pThr is substi-
tuted by pSer is only a local effect, and the entropy loss
of the whole system with phosphopeptide binding was
not computed and compared in this work. The local
interaction energy and local entropy calculations offer
quantitative comparison for pSer- and pThr-containing
peptide binding, and we do not suggest that the binding
energy loss may be fully compensated by the local
entropy gain in this study.
The second phosphoresidue-binding site of Dun1-FHA
and Ki67-FHA
Some FHA domains also show the second phosphore-
sidue-binding site, and knowing whether the second
Table 2 Global MM-PBSA energy calculations
domain mutated site mutation ΔΔUVDW ΔΔUCoul ΔΔWPB ΔΔEele ΔΔEtot-np ΔΔWnp ΔΔEtot
Rad53-FHA1 1 pT®pS 2.50 -34.34 37.83 3.49 5.99 0.75 6.74
Rad53-FHA1 1 pT®pS 0.44 -13.74 16.08 2.33 2.77 0.72 3.49
Dun1-FHA 1 pT®pS -2.63 -13.70 18.84 5.15 2.52 2.34 4.86
Ki67-FHA 1 pT®pS 4.30 -8.77 7.79 -0.98 3.32 -0.84 2.48
Dun1-FHA 2 pT®pS -2.54 -59.30 63.39 4.09 1.55 1.95 3.50
Ki67-FHA 2 pS®pT 0.94 19.77 -20.15 -0.38 0.55 0.36 0.91
BRCT 1 pS®pT -3.33 28.77 -23.67 5.10 1.77 0.84 2.61
WW 1 pS®pT -1.03 -39.75 36.78 -2.96 -3.99 -0.01 -4.00
ΔΔUCoul and ΔΔUvdw are the electrostatic and van der Waals interactions, respectively, between the wild-type and mutants; ΔΔWPB and ΔΔWnp are the polar and
non-polar contributions from the solvation energy. ΔΔEele represents the sum of ΔΔUCoul and ΔΔWPB. ΔΔ indicates the changes between two calculations of the
mutated and non-mutated state. For example, ΔΔUVDW = ΔUVDW,pSer-ΔUVDW,pThr, where ΔUVDW is the interaction energy between the phosphopeptide and the
domain.
Table 3 Local MM-PBSA energy calculations
domain mutated site mutation ΔΔUVDW ΔΔUCoul ΔΔWGB ΔΔEele ΔΔEtot-np ΔΔWnp ΔΔEtot
Rad53-FHA1 1 pT®pS 3.12 -8.36 5.71 -2.65 0.46 0.03 0.49
Rad53-FHA1 1 pT®pS 0.23 -9.64 10.93 1.29 1.52 -0.12 1.40
Dun1-FHA 1 pT®pS 2.30 3.00 -0.71 2.29 4.59 0.06 4.66
Ki67-FHA 1 pT®pS 3.22 2.25 -1.67 0.58 3.80 0.14 3.94
Dun1-FHA 2 pT®pS 0.49 -1.30 -0.26 -1.57 -1.07 0.00 -1.07
Ki67-FHA 2 pS®pT 0.70 3.33 -2.02 1.30 2.01 0.09 2.10
BRCT 1 pS®pT 0.06 7.17 -6.75 0.41 0.47 0.08 0.56
WW 1 pS®pT -1.85 1.67 0.10 1.78 -0.07 0.05 -0.02
We selected residues within 5 to 7 Å around pThr/pSer residues. The residues selected are in the Additional file 1. Table S3. The notations are the same in Table
2.
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therefore studied two diphosphoresidue-recognized
FHA domains, Dun1-FHA and Ki67-FHA. Both
domains have one pThr binding to the main pThr-
binding site, but they also have one more phosphoresi-
due, pSer or pThr, in the peptide sequences. One main
difference between the main pThr and the second
phosphoresidue-binding site is that the main pThr-
binding site consists of two loops that form a well-
defined pocket, whereas the second binding site is
located in areas with a single loop. To understand
whether the difference contributes to residue specifi-
city, we mutated the phosphoresidue available in the
experiment, pThr of Dun1-FHA and pSer of Ki67-FHA
to pSer and pThr, respectively.
Overall, the global binding energy calculations show
that for the second phosphoresidue-binding site, the
mutations worsen binding affinities (see Table 2), but
the changes are smaller than the values for the main
pThr-binding site. However, the local interaction energy
calculations do not show the same trend, and the muta-
tion of Dun1-FHA is preferable. Therefore, the calcula-
tions do not directly support that the domain strongly
p r e f e r se i t h e rp T h ro rp S e ri nt h es e c o n dp h o s p h o r e s i -
due-binding site. The local interaction energy calcula-
tions suggest that pSer can have good interactions with
the domain, which are contributed mainly from the
electrostatic attractions, and by losing the methyl group,
the van der Waal interactions are weakened, but not sig-
nificantly. As illustrated in Figure 2 (B2) and (B3), the
Figure 3 Distribution of a dihedral angle of the phosphoresidue. (i) Plots of the dihedral angle with five seeds are shown in frame index 1-
100, 101-200, 201-300, 301-400 and 401-500, respectively and (ii) corresponding population distributions. Column (A) shows the dihedral angle of
pThr (1) or pSer (2) used for plotting. (B), (C), (D) and (E) indicate the binding area in the main binding site of FHA, the second binding site of
FHA, the pThr/pSer binding site of BRCT repeats and the WW domain, respectively.
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two Arg residues, Arg62 and Arg64, to recognize pThr
or pSer and form multiple H-bonds with the phosphate
group. Therefore, the electrostatic attractions are the
major driving forces in pThr/pSer binding is not sur-
prising [56]. In addition, both Arg residues are located
in one single loop, which is a flexible region of FHA
domains, so the protein is freely adjustable to adopt
both pThr and pSer. Although the methyl group of
pThr forms non-polar attractions with the alkane
branch of Arg62 shown in Figure 2 (B2), the binding
site does not hold a small pocket when pThr is substi-
tuted by pSer (Figure 2 (B3)), because the space is filled
by the nearby FHA domain sidechains.
The second phosphoresidue-binding site is located in
as i n g l el o o p ,b3-b4, and without spatial constraint, the
second site allows the FHA domain to rearrange side-
chains to optimize both pThr and pSer binding. We
Figure 4 Detailed illustration of conserved His interactions in Rad53-FHA1. (A) Overall FHA structure. Conserved His is in red; other residues
around His that contribute to form a pThr binding pocket are in orange. The phosphopeptide and pThr are in cyan. (B) Cartoon representation
of two loops held by His and the nearby residues. Red dashed lines indicate interactions between residues. (C) MD simulation snapshots with
time. Atom pairs with electrostatic attractions are labeled with blue dashed lines.
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Page 9 of 13therefore examined changes in local flexibility when a
different phosphoresidue stays in this binding site, and
we focused on dihedral angles of the phosphate group
of pThr and pSer. Both residues do not expressly reveal
dynamic motions in either complex, but the most popu-
lated angles modeled from our MD simulations shift
more than 20° (Figure 3 (C1) (C2)). Although the dihe-
dral angle has only one rotameric states in both cases,
pThr has smaller vibration range and the configuration
entropy is 0.5-1.0 kcal/mol smaller than pSer, presum-
ably due to a bulkier methyl group. The entropy
changes between pThr and pSer is less pronounced in
the second phosphoresidue-binding site than in the
main one. Moreover, the motions of backbone dihedrals
remain the same, which indicates the negligible influ-
ence of the mutation.
In conclusion, the main pThr-binding site has a
unique feature to recognize pThr, and a special pocket
built by linking two loops with the conserved His is
reserved for the methyl group of pThr, which plays a
crucial role in distinguishing between pThr and pSer.
However, the second phosphoresidue binding site is
positioned in a single loop near the N-terminus, which
uses two Arg residues to recognize a phosphate group
but lacks a well structured binding cavity to identify
only pThr or pSer. Our simulations show that the pro-
tein sidechain of the binding site changes when pThr or
pSer binds to the domain. Therefore, a single loop used
to provide a phosphoresidue-binding site cannot discri-
minate pThr/pSer but can bind to both residues. Other
domains, such as the WW domain, also use a similar
strategy, as discussed in the next section. Of note,
although not within the scope of this paper, the promis-
cuous domain has preferences for selected sequences,
and the peptide sequences also play an important role
in the phosphopeptide-binding site.
BRCT repeats and WW domain recognize both pThr and
pSer
The BRCT and WW domains are distinct pSer/pThr
binding domains. Not all BRCT and WW domains
function as phosphopeptide binding modules, but both
have a subset that binds to phosphopeptides. Both
domains can bind to particular sequences that contain
pSer or pThr, but in general, tandem BRCT domains
bind stronger to pSer than pThr and WW domains
h a v eap r e f e r e n c ef o rp T h rp r e c e d i n gaP r o[ 2 8 , 3 3 ] .
Note that pSer or pThr must be followed by Pro, for
pSer/pThr-Pro sequences for binding to WW domains.
In contrast to FHA domains, which bind exclusively to
pThr-containing peptides, BRCT and WW domains do
not recognize solely pThr- or pSer-containing peptides.
Although proteins that treat Ser and Thr as similar resi-
dues may be common, knowing how both domains have
a specific or non-specific pThr/pSer recognition is of
interest.
Both global binding energy and local interaction energy
calculations suggest that the tandem BRCT domains pre-
fer the pSer- than pThr-containing sequence, although
the preference is not strong. The local interaction ener-
gies shown in Table 3 suggest that pSer can form a more
favorable electrostatic attraction, ~0.5 kcal/mol more
negative than that contributed by pThr binding, but the
difference is relatively small. In addition, our simulations
show that most of the time, the methyl group of pThr
does not directly interact with the domain, as demon-
strated by a representative complex conformation in Fig-
ure 2 (C2). As a result, we see a negligible difference in
van der Waal interactions in the local interaction energy
calculations (see Table 3), and the electrostatic attractions
are the main driving forces to recruit phosphopeptides
binding to tandem BRCT domains (Table S2 in Addi-
tional file 1). The phospho recognition is through form-
ing interactions with Lys1702 in an a helix and Ser1655
and Gly1656 near the loop, where no small cavity is
reserved for the methyl group of pThr. Although the
methyl group is not directly involved in binding, the local
arrangement of the phosphate group is changed, but the
overall flexibility of the phosphate group remains similar
(Figure 2 (C)).
Although the WW domains are able to recognize both
pSer- and pThr-containing peptides, global binding
Table 4 Configuration entropy changes
domain mutated site mutation TΔSphi TΔSpsi TΔSomega TΔSsidechain TΔStotal
Rad53-FHA1 1 pT®pS 0.18 0.29 0.03 1.39 1.91
Rad53-FHA1 1 pT®pS 0.37 0.37 0.14 1.26 2.16
Dun1-FHA 1 pT®pS -0.25 -0.08 0.00 0.72 0.45
Ki67-FHA 1 pT®pS 0.25 0.32 0.14 1.50 2.23
Dun1-FHA 2 pT®pS 0.10 -0.01 0.00 1.03 1.12
Ki67-FHA 2 pS®pT -0.04 -0.06 0.01 -0.47 -0.57
BRCT 1 pS®pT -0.08 0.01 0.00 0.35 0.28
WW 1 pS®pT -0.15 -0.01 -0.12 -0.71 -1.01
Configuration entropy changes (kcal/mol) for phi, psi, omega and sidechain dihedrals of phosphoresidue in the wild-type and mutants.
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Page 10 of 13energy calculations suggest that the domain favors pThr
because of the more preferable van der Waals attrac-
tions. The trend is in agreement with experimental
results [33]. However, the local interaction energy calcu-
lations show that the favorable van der Waals attrac-
tions are mostly compensated by weaker electrostatic
interactions. As shown in Figure 2 (D2) and (D3), two
conserved aromatic residues of the domain, Tyr and
Trp, create a cavity, but no sidechains of phosphopep-
tides could nicely fit into the cavity during our simula-
tions. Interestingly, the conserved Pro residue adjacent
to the phosphoresidue is clamped by Tyr and Trp,
which stays in the cavity and further restricts nearby
phosphopeptide conformations. The confined region
formed by rings of Tyr, Trp and Pro is conserved
regardless of the presence of pSer or pThr (see Figure 2
(D2) and (D3)), which also explains the crucial roles of
Pro. Because of the bulky ring conformations, an empty
space is observed during the course of the simulations.
The empty space can be partially filled by the methyl
group of pThr, thus resulting in more favorable van der
Waals interactions and a less flexible sidechain while
pThr is binding. However, the Pro residue but not the
methyl group of pThr primarily occupies the cavity in
phosphopeptide recognition. Therefore, the domains do
not show significant discrimination between pSer and
pThr.
Comparisons between FHA domains and tandem BRCT
repeats and WW domain
FHA domains use the conserved His to bridge two
loops, b4-b5a n db6-b7, to construct the main pThr
binding, which have a phosphate group binding site and
preserve a small pocket nicely fit by the methyl group of
pThr (see Figure 4(C)). Without the methyl group,
neither pSer binding nor rearranging sidechains of FHA
near the methyl binding site can effectively fill the
pocket, which results in unsuccessful binding. The sec-
ond binding site of FHA domains makes use of a single
loop to recognize pThr/pSer, and WW and BRCT
domains combine a single loop and a nearby a helix
(BRCT domains) or b sheet (WW domains) to bind to
pThr/pSer. The structures of these phosphoresidue
binding sites allow the protein sidechains to be adjusta-
ble to both pThr and pSer residues. Notably, although
loops are usually considered flexible regions of a protein,
the dual loops in the main pThr-binding site of FHA
domains show an interaction network between the loops
to form a pre-organized binding cavity for pThr (data
not shown). Besides the unique features of using dual
loops specifically for pThr binding, all other phosphore-
sidue binding sites share common characteristics that
include a binding site comprised of positive-charged
residues to form Coulombic attractions with the
phosphate group and geometry complementary in the
binding surface.
Of note, the binding affinities of phosphopeptide
binding to these domains are in general weak, in the
micromolar range (see Table 1); therefore, weakened
attractions by a few kcal/mol can completely diminish
the phosphopeptides binding. Therefore, although sub-
stitution of pThr by pSer mainly reduces van der
Waals attractions in the main pThr binding site of
FHA domains, the pSer-containing peptide cannot
form the domain-peptide complex. Different from
other phosphopeptide binding sites, sidechain rearran-
gements cannot bring other attraction forces to com-
pensate for the loss of the van der Waals interactions
because of the rigid structure formed by His and the
dual loops. In addition to energy calculations, our local
entropy calculations suggest that binding pThr to the
main pThr-binding site of FHA can reduce the mobi-
lity significantly, which indicates stronger attraction
and more geometry confinement. However, the
entropy changes between pThr and pSer binding to
other domains show smaller differences, which sug-
gests that the system retains a similar dynamic beha-
vior that may help balance energy loss by gaining
other attractions.
Biological implication
Modular domains are common regulators in important
biological processes. This work studied three important
domains for DNA damage responses, FHA, BRCT and
WW domains, all with a phosphopeptide binding site to
relay the damage signal and trigger further repair. The
specific peptide can be recognized by three different
proteins: a protein kinase to phosphorylate Ser/Thr, a
modular domain that binds to the phosphopeptide for a
downstream process, and a phosphatase to dephosphor-
ylate the phosphoresidue. Kinases involved in the DNA
damage response, ATM and ATR, can phosphorylate
both Ser and Thr of a substrate. Similar to kinases,
phosphatases work for both pThr and pSer [57], and
most phosphodomains can also bind to both pThr- and
pSer-containing peptides. FHA domains have evolved a
simple but remarkable mechanism to specifically recog-
nize pThr to further select particular partners after
kinase phosphorylation. For example, a binding partner
of FHA domains, the SCD protein family, contains rich
Thr-glutamine (TQ) and Ser-glutamine (SQ) repeat
motifs [58]. Although the kinase phosphorylates both
Thr and Ser, Rad53-FHA1 can bind only to regions that
have pThr. How binding to the particular pThr region
triggers further responses is unclear, but the pThr-only
recognition may play a role in regulation. The mechan-
ism contributing to pThr binding brings insights into
how modular domains differentiate pThr and pSer or
Huang and Chang BMC Biophysics 2011, 4:12
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Page 11 of 13recognize both residues. The information aids in the
design and discovery of phosphopeptides to access the
cellular function of the domain-containing proteins. The
rigid dual loops centered on the conserved His in the
main pThr binding site of FHA domains may be applied
to protein engineering that may need to recognize small
functional groups.
Conclusions
In this study, we performed dynamic-guided process for
FHA, BRCT and WW domain-peptide structures. The
components of detailed interaction energies were calcu-
lated by MM-PBSA/MM-GBSA method. The main
pThr-binding cavity is identical in four different FHA
complexes. Our results reveal FHA domain uses the
conserved His residue to define a dual loops structure
which shows strong favor for pThr because of the geo-
metry of methyl group embedded in deep binding
pocket nicely. The dynamics simulations, energy and
entropy calculations indicate that the phosphoresidue
binding site of FHA is highly suited to pThr, and small
changes of pThr to pSer can diminish the domain-pep-
tide interactions due to the pre-organized binding cavity.
On the other hand, BRCT repeats and WW domain uti-
lize the combination a single loop with a-helix or b-
sheet which allows effectively sidechain rearrangement
to accept both pSer and pThr. The results highlight
broader implications in recognition pathway of kinase/
phosphotase and also help to engineer proteins and
design peptide inhibitors.
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